1. Home
  2. MGYR vs GOSS Comparison

MGYR vs GOSS Comparison

Compare MGYR & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

N/A

Current Price

$16.10

Market Cap

115.2M

Sector

Finance

ML Signal

N/A

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.43

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
GOSS
Founded
1922
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.2M
101.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
MGYR
GOSS
Price
$16.10
$0.43
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
8.5K
26.2M
Earning Date
04-29-2026
03-17-2026
Dividend Yield
2.33%
N/A
EPS Growth
26.83
N/A
EPS
0.50
N/A
Revenue
N/A
$48,471,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$203.01
P/E Ratio
$34.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.52
$0.33
52 Week High
$20.00
$3.87

Technical Indicators

Market Signals
Indicator
MGYR
GOSS
Relative Strength Index (RSI) 41.80 23.42
Support Level $16.81 $0.33
Resistance Level $17.21 $0.60
Average True Range (ATR) 0.35 0.06
MACD -0.04 0.06
Stochastic Oscillator 18.95 0.00

Price Performance

Historical Comparison
MGYR
GOSS

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: